LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Stryker Corp

Closed

SectorHealthcare

376.43 2.06

Overview

Share price change

24h

Current

Min

365.04

Max

377.16

Key metrics

By Trading Economics

Income

-10M

849M

Sales

1.1B

7.2B

P/E

Sector Avg

43.681

110.024

EPS

4.47

Dividend yield

0.93

Profit margin

11.839

Employees

56,000

EBITDA

351M

1.7B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+17.71% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.93%

2.26%

Next Earnings

30 Apr 2026

Next Dividend date

30 Apr 2026

Next Ex Dividend date

31 Mar 2026

Market Stats

By TradingEconomics

Market Cap

3.6B

140B

Previous open

374.37

Previous close

376.43

News Sentiment

By Acuity

34%

66%

103 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Stryker Corp Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jan 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

30 Oct 2025, 20:36 UTC

Earnings

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 Jul 2025, 20:42 UTC

Earnings

Stryker Lifts Guidance on Improving Tariff Outlook

1 May 2025, 20:56 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

30 Jan 2026, 17:03 UTC

Market Talk

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 Jan 2026, 21:07 UTC

Earnings

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 Jan 2026, 21:05 UTC

Earnings

Stryker 4Q Adj EPS $4.47 >SYK

5 Nov 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 Nov 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 Oct 2025, 20:21 UTC

Earnings

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.1B >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.06B >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

31 Jul 2025, 20:09 UTC

Earnings

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sales >SYK

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Net $884M >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Adj EPS $3.13 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

17.71% upside

12 Months Forecast

Average 430.89 USD  17.71%

High 469 USD

Low 387 USD

Based on 19 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

16

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

373.92 / 383.99Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

103 / 351 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat